Castleman's disease (CD), also known as angiofollicular lymphoid hyperplasia, was initially described in 1956 1 in asymptomatic patients with mediastinal lymphadenopathies. It can also present as a multicentric disorder affecting the pelvic 2 , inguinal 3 , retroperitoneal 4, 5 and other lymph nodes. There have been aproximately 400 cases described in the literature. The exact incidence is unknown. The age distribution shows a peak frequency at about 45 years. There is no significant difference in gender distribution.
The aetiology of CD is not well known. It has been recently suggested that abnormal production of a B cell growth factor, such as IL-6, in the hyperplastic lymph nodes causes lympho-proliferation and plasma cell differentiation 6 . The most characteristic histopathological findings are follicular hyperplasia with perifollicular vascular endothelial proliferation. Histologically, two variants of CD are recognized: hyaline-vascular type (91%) and plasma cell type (9%), also known as Flendring's type I and II 6 . There is also an intermediate type.
CD has two main clinical presentations 7 . In the localized disease, 80% of the cases correspond to the hyaline-vascular type and the remaining 20% to the plasma cell type (children and young adults). This localized form presents most frequently as a solitary mass within the chest and has minimal or no general symptoms. Surgical excision is usually curative and the prognosis is excellent with a 100% five-year survival rate after surgery. The multicentric form of the disease is usually due to the plasma cell variant. It is associated with systemic manifestations 8, 9 and has a mortality close to 50%, with a mean survival of 26 months despite chemotherapy. Lesions can affect the lungs, kidneys, muscle, pericardium, central nervous system and vulva. The management of multicentric CD requires a multimodal approach. Pre-anaesthetic assessment should assess the presence of associated pathologies which may influence the choice of anaesthetic.
A MEDLINE search using appropiate keywords showed no previous articles in the medical literature linking "anaesthesia" with "Castleman's disease". Due to the rarity of this disease and the possibility of associated conditions which may influence anaesthesic management, we present the following case.
CASE HISTORY
A 27-year-old female patient, 172 cm in height and weighing 70 kg, presented for vaginal reconstruction. Vaginal occlusion had occurred after recurrent sores related to CD. CD had been detected two years previously, after dermatological investigation of severe canker sores. Haematological tests revealed lymphopenia. Further investigations included CT scanning which demonstrated an adrenal mass. Left nephrectomy was performed under general anaes-thesia with no complications. Histology of the adrenal mass showed CD (hyaline-vascular variant) and systemic steroid therapy was initiated.
Before surgery for vaginal reconstruction, an exhaustive preoperative evaluation was performed. The patient suffered from asthma (treated with inhaled beta-adrenergic agonists), myopia, and Sjögren's syndrome. Physical examination demonstrated canker sores and loss of nails. Auscultation of the chest showed diffuse wheezing on the right side, but the patient had no dyspnoea. Auscultation of the heart, ECG and echocardiography were normal. Chest X-ray and thoracic CT did not show any mediastinal mass. Renal and liver function tests were normal and haematological studies demonstrated only lymphopenia. Neurological examination and spinal MRI were also normal. The patient was being treated with oral prednisone 30 mg in the morning every 48 hours.
The night before surgery and one hour before induction of anaesthesia, the patient was given intravenous hydrocortisone 100 mg and ranitidine. In the operating room, standard monitoring was established with continuous ECG, non-invasive blood pressure and pulse oximetry. A combined spinal-epidural anaesthetic was performed. The L4-L5 space was used for intrathecal injection of 10 mg of 0.5% hyperbaric bupivacaine with a 25 gauge Whitacre-Yale® spinal needle. The L3-L4 space was used to place a 20 gauge epidural catheter, (Perifix ® -Braun) via an 18G Tuohy needle. A 12 ml bolus of 0.5% isobaric bupivacaine was given epidurally. A target-controlled intravenous propofol infusion 2 µg/ml was employed for sedation. The surgical procedure, which lasted 55 minutes, consisted of vaginal dilatation and placement of a vaginal expander. There was no significant blood loss and the patient remained haemodynamically stable and comfortable, with no pain during the procedure or in the immediate postoperative period.
Continuous epidural infusion with 0.2% ropivacaine 12 ml/h was used for 48 hours for postoperative pain management. The patient had VAS pain scores between 0 and 3 and did not require other analgesia.
DISCUSSION
Preoperative assessment of patients with CD should determine whether the patient has any of the associations of CD which might influence the anaesthesia. Most cases are asymptomatic. Localized mediastinal masses composed of multiple and enlarged lymph nodes may occur. CD can be associated with a wide range of conditions (Table 1) 10-15 . CD may present with non-specific signs, symptoms and laboratory abnormalities such as fever, weight loss and drowsiness, anaemia, elevated erythrocyte sedimentation rate, hypergammaglobulinaemia or hypoalbuminaemia 7 . Other manifestations include hepatomegaly, skin rash, and predisposition to infection.
Multicentric CD is an aggressive illness, usually with a fatal course. Infection is the commonest cause of death 7 . There is also an association with the development of malignant tumours such as lymphoma or Kaposi's sarcoma. Multicentric disease has been associated with both HIV infection and co-infection with human herpesvirus-8(HHV-8). Infection can be related to immunosupression caused by the disease or its treatments (steroids and chemotherapy). Our patient had lymphopenia and had received long-term steroid treatment. In view of this increased risk of infection, rigorous aseptic measures were employed during peripheral venous cannulation, anaesthesic procedures and surgical wound care. There were no infective complications during the perioperative period.
One of the most hazardous pathologies which could arise from the localized form of CD is an anterior mediastinal mass. Respiratory tract obstruction, potentially at a bronchial level, and circulatory collapse due to great vessel obstruction may occur with induction of anaesthesia. Careful planning, with anaesthesia only undertaken when alternatives are not available, with consideration of techniques which maintain spontaneous ventilation and functional residual capacity, may lessen the chance of cardiorespiratory catastrophe. We excluded mediastinal mass in our patient with thoracic CT. When oral or nasal sores secondary to CD are present, endotracheal intubation may be complicated by bleeding.
The choice of spinal anaesthesia was based on the type of surgery and on the absence of absolute or • Pemphigus vulgaris.
• Temporal arteritis.
• Hypergammaglobulinaemia.
• Hypoalbuminaemia and refractory anaemia.
• Thrombocytopenic purpura.
• Nephrotic syndrome.
• POEMS syndrome (Takatsuki's syndrome).
• HIV.
• Kaposi's sarcoma.
• Lymphoma.
• Rheumatoid arthritis.
• Sjögren' syndrome.
• Features of autoimmune diseases (antinuclear antobodies, autoimmune haemolytic anaemia, cryoglobulinaemia, autoimmune serum complexes).
relative contraindications. Platelet count and coagulation parameters were in the normal range and there was no neurological damage related to CD. Regional anaesthesia may also have some advantages over general anaesthesia in a patient with asthma. The neck is the most common site of extrathoracic presentation 16 . This, combined with the potential for oral (tongue, palate, and nasopharynx), perioral infiltration (sternomastoid region, submandibular region) and steroid-induced facial-truncal obesity can also cause significant difficulty with tracheal intubation and ventilation. Appropriate equipment and staff should be available. Bronchiolitis obliterans can be associated with CD and usually has a poor prognosis 17 , being very resistant to treatment (steroids, chemotherapy, plasmapheresis). Some cases of CD develop respiratory distress syndrome 10 . The central nervous system can also be affected by CD. It is rarely localized to the epidural space but infiltration of meninges, subdural, paravertebral and intracranial spaces has been described 18, 19 . A sensorimotor neuropathy is the most frequent neurological manifestation. Preoperative assessment should include neurological examination and CT and/or MRI of the CNS as indicated. CD is also associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes) 13 raising the possibility of endocrine or neurological pathology which should be assessed preoperatively 15 . None of these aspects of CD were found in our patient. Neuropathies should be considered as relative contra-indications for spinal anesthesia and central nervous system infiltrations or masses as absolute contra-indications for these procedures. In the rare cases of CD associated with myasthenia gravis 10 , muscle relaxant drugs should be used with care and careful monitoring.
Preoperative cardiorespiratory assessment should take into account the fact that pericarditis is the most common form of cardiac disease in CD and can cause cardiac tamponade 20 . Clinical signs may be evident but echocardiography is the most useful investigation to exclude this complication. Cases of renal amyloidosis with variable degrees of renal insufficiency and nephrotic syndrome have been associated with CD 12 . In cases with renal impairment, care should be taken to avoid further renal insults such as hypovolaemia and nephrotoxic drugs. It may also be necessary to adjust the dose of drugs excreted by the kidney.
In conclusion, when anaesthesia is required in a patient with CD, preoperative evaluation needs to consider the wide-ranging possible associations of the condition which may influence anaesthetic management.
